Imran Eba is a founding partner at Action Potential Venture Capital, GlaxoSmithKline’s venture capital fund focused on investing in companies that pioneer bioelectronic medicines. Imran represents Action Potential as a board member in NeuSpera Medical, SetPoint Medical, Axon Therapies and Alpheus Medical. Imran is also a founding member and program advisor to the Harvard Healthtech Fellowship which aims to bring together innovators from the fields of engineering, technology and medicine to discover and develop novel non-drug therapies with the vision of making Boston a powerhouse in this field as it has been in biotech.
Prior to his role at Action Potential, Imran headed up GSK’s Investment Management group and was responsible for accessing technology and innovation external to GSK by making and managing investments in life science venture capital funds as limited partners and direct investments in biotechs. Imran is originally from Montreal but is based in Cambridge, Massachusetts.